Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown that this can be painful.

| More on:
The Motley Fool

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in danger of defaulting on its debt, which would be yet another catastrophe for shareholders. To save itself from that fate, it is currently negotiating with its lenders to ease covenants.

But this has consequences too, as has been demonstrated by a number of oil companies. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) is one example. We’ll take a closer look below.

Valeant’s covenants

According to Valeant’s credit agreement, a default will occur if Valeant doesn’t file its 10-K (which includes audited financial statements) by the end of this month. In that scenario, Valeant will then have 30 days to cure the default by filing its 10-K.

Meanwhile, Valeant has already breached the reporting covenant in its bond indentures, which required a 10-K by March 16. As a result, the company is restricted from borrowing any more money from its revolver.

These aren’t the only covenants Valeant must adhere to; there are also certain financial targets that the company must maintain. The company said it expects to be in compliance with all covenants this year and next, but until the company releases audited financials, it’s impossible to know for sure.

Penn West’s experience

At the beginning of last year Penn West was about to breach its debt covenants, which would have meant a default. To avoid such a fate, the company got lenders to relax covenants. And even though an agreement was reached, it was not a fun process.

For starters, Penn West had to lower its quarterly dividend from $0.03 to $0.01. The company also had to cancel a $500 million tranche in its bank facility. It also had to grant floating charge security over all its property. If that wasn’t bad enough, Penn West had to pledge that any asset sales would go towards reducing debt. To top it all off, the company had to agree to higher interest payments.

Anything can happen

This situation with Valeant is a little different, because Valeant hasn’t even released audited financials, making the outcome very unpredictable. Otherwise, Penn West’s experience provides a useful learning experience.

And anonymous sources have already told Reuters that “creditors prepare to slam company with tougher demands” in exchange for relaxing covenants. So one way or another, Valeant is in for a rough ride. This story is far from over.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Investing

The Secrets That TFSA Millionaires Know

The top secrets of TFSA millionaires are out and can serve as a roadmap for the next millionaires.

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Investing

Got $3,000 for a TFSA? 3 Reliable Canadian Stocks for Long-Term Wealth Building

These Canadian stocks have strong fundamentals and solid growth potential, which makes them reliable stocks for building wealth.

Read more »

Investor wonders if it's safe to buy stocks now
Energy Stocks

Canadian Natural Resources: Buy, Sell, or Hold in 2026?

Buy, Sell, or Hold? Ignore the speculative headlines. With a 5.2% yield and 3% production growth, Canadian Natural Resources stock…

Read more »

Income and growth financial chart
Dividend Stocks

A Canadian Dividend Stock Down 9% to Buy Forever

TELUS has been beaten down, but its +9% yield and improving cash flow could make this dip an income opportunity.

Read more »

dividend growth for passive income
Dividend Stocks

Top Canadian Stocks to Buy for Dividend Growth

These less well-known dividend stocks offer amazing potential for generating increasing income for higher-risk investors.

Read more »

man touches brain to show a good idea
Retirement

Here’s the Average TFSA and RRSP at Age 45

Averages can be a wake-up call, and Manulife could be a simple, dividend-paying way to help your TFSA or RRSP…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

2 Stocks That Could Turn $100,000 Into $0 Faster Than You Think

Canopy Growth and Plug Power are two unprofitable stocks that remain high-risk investments for shareholders in 2026.

Read more »

Real estate investment concept
Dividend Stocks

Down 23%, This Dividend Stock is a Major Long-Time Buy

goeasy’s big drop has pushed its valuation and yield into “paid-to-wait” territory, but only if credit holds up.

Read more »